KR20030012563A - Feed compound for substituting antibiotic - Google Patents

Feed compound for substituting antibiotic Download PDF

Info

Publication number
KR20030012563A
KR20030012563A KR1020010046638A KR20010046638A KR20030012563A KR 20030012563 A KR20030012563 A KR 20030012563A KR 1020010046638 A KR1020010046638 A KR 1020010046638A KR 20010046638 A KR20010046638 A KR 20010046638A KR 20030012563 A KR20030012563 A KR 20030012563A
Authority
KR
South Korea
Prior art keywords
weight
feed
feed composition
antibiotics
livestock
Prior art date
Application number
KR1020010046638A
Other languages
Korean (ko)
Inventor
김정우
Original Assignee
주식회사 단바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 단바이오텍 filed Critical 주식회사 단바이오텍
Priority to KR1020010046638A priority Critical patent/KR20030012563A/en
Publication of KR20030012563A publication Critical patent/KR20030012563A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/20Animal feeding-stuffs from material of animal origin
    • A23K10/22Animal feeding-stuffs from material of animal origin from fish
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins

Abstract

PURPOSE: A substitute feed composition for antibiotics is provided, thereby easily increasing immunity and health of domestic animals without using antibiotics. CONSTITUTION: The substitute feed composition for antibiotics comprises 0.1 to 10 wt.% of eggs containing IgY obtained from laying hens immunized by an antigen selected from the group consisting of F4:K88, F5:K99, F6:987P, F18 and F41. It further comprises 35 to 45 wt.% of corns, 20 to 30 wt.% of dried whey, 10 to 20 wt.% of soybean waste, 5 to 15 wt.% of soybean protein, 0.5 to 8 wt.% of spray-dried blood, 0.5 to 8 wt.% of fish protein powder, 1 to 5 wt.% of animal lipid, 0.5 to 5 wt.% of calcium phosphate, 0.05 to 3 wt.% of limestone, 0.05 to 1 wt.% of premix of vitamin and mineral, 0.01 to 3 wt.% of salt, 0.01 to 3 wt.% of lysine, and 0.01 to 3 wt.% of methionine.

Description

항생제 대체를 위한 사료 조성물{FEED COMPOUND FOR SUBSTITUTING ANTIBIOTIC}Feed composition for antibiotic replacement {FEED COMPOUND FOR SUBSTITUTING ANTIBIOTIC}

본 발명은 항생제 대체를 위한 사료 조성물에 관한 것으로서, 더욱 상세하게는, 동물의 세균성 질병을 예방 및 치료할 수 있는 항체를 포함하는 난을 혼합하여 제조되는 가축사료 조성물에 관한 것이다.The present invention relates to a feed composition for replacing antibiotics, and more particularly, to a livestock feed composition prepared by mixing eggs containing antibodies capable of preventing and treating bacterial diseases in animals.

항생제가 양돈사료에 첨가되어 사용되면 동물의 질병예방 및 치료효과와 함께 성장촉진 및 사료효율이 개선된다는 보고가 있었으며(Hays, V. W. 1977. Effectiveness of feed additive usage of antimicrobial agents in swine and poultry production. Office of technology assessment, US congress, Washington D. C.(eds: Hays, V. W. 1981. The Hays report. Rachelle Laboratories, Inc., Long Beach, CA) ; Zimmerman, D. R. 1986.J. Anim. Sci. 62(Suppl. 3): 6), 1950년대 이후부터 양돈사료에 항생제를 혼합하여 사용하였다(Cromwell, G. L. 1991. Antimicrobial agents. Swine Nutrition(eds: E. R. Miller, Ullery, D. E. and Lewis, A. J.). Butterworth-Heinemann. P. 297).The use of antibiotics in pig feed has been reported to improve animal growth prevention and feed efficiency, as well as to prevent and treat disease in animals (Hays, VW 1977. Effectiveness of feed additive usage of antimicrobial agents in swine and poultry production.Office of technology assessment, US congress, Washington DC (eds: Hays, VW 1981.The Hays report.Rachel Laboratories, Inc., Long Beach, CA); Zimmerman, DR 1986. J. Anim. Sci . 62 (Suppl. 3) 6), since 1950, pig feed has been mixed with antibiotics (Cromwell, GL 1991. Antimicrobial agents. Swine Nutrition (eds: ER Miller, Ullery, DE and Lewis, AJ). Butterworth-Heinemann.P. 297 ).

그러나, 육제품내의 항생제 잔류와 항생제 내성균에 대한 공중보건학적 관심이 고조되면서(Braude, R. 1978.J. Anim. Sci. 46:1425-1436 ; Kunin, C. M. 1993.Ann. Intern. Med. 118:557-561 ; Cassel, G. H. 1995. ASM News. 61(3):116-120), 항생제 대체물질을 개발하고자 하는 연구가 양돈산업에서 진행되고 있다(Vanbelle, M. 1989. Biotechnology in the feed industry. pp 191. Proc. of Alltech's 5th Annu. Symp. Alleth Tech. Publ., Nicholasville, KY.).However, as public health interest in antibiotic residues and antibiotic resistant bacteria in meat products has increased (Braude, R. 1978. J. Anim. Sci . 46: 1425-1436; Kunin, CM 1993. Ann.Intern . Med . 118). (557-561; Cassel, GH 1995. ASM News. 61 (3): 116-120), research is underway in the pig industry to develop antibiotic substitutes (Vanbelle, M. 1989. Biotechnology in the feed industry pp 191. Proc. of Alltech's 5th Annu.Symp.Alleth Tech.Publ., Nicholasville, KY.).

신생가축은 어미의 초유에 존재하는 항체를 섭취하여 면역성을 지니게 되므로, 조기이유는 신생가축의 질병에 대한 방어를 약화시켜 질병발생을 크게 증가시킨다.Since the new livestock is immunized by ingesting antibodies present in the colostrum of the mother, the early reason weakens the defense against the disease of the new livestock and greatly increases the incidence of disease.

초유를 먹지 않은 신생자돈에게 장독성대장균 K88, 987P와 K99의 섬모 유착(fimbrial adhesin)에 대한 특이항체를 경구투여하면 설사병이 완전히 예방되었다는 보고가 있다(Yokoyama, H., Hashi, T., Umeda, K., Icatlo Jr, F. C., Kuroki, M., Ikemori, Y. and Kodama, Y. 1997.J. Ver. Med. Sci. 59:917-921).It has been reported that diarrhea was completely prevented by oral administration of colostrum-free E. coli K88, 987P and K99 specific antibodies to fimbrial adhesin (Yokoyama, H., Hashi, T., Umeda). , K., Icatlo Jr, FC, Kuroki, M., Ikemori, Y. and Kodama, Y. 1997. J. Ver. Med. Sci . 59: 917-921).

난황내의 면역글로블린은 면역글로블린의 원료로서 이용될 수 있을 뿐만 아니라, 식품원료로서 효과적으로 이용될 수 있다(Shimizu, M., Fitzsimmons, R. C. and Nakai, S. 1988.J. Food. Sic. 53(5):1360-1366). 특히, 로즈 등(Rose, M. E., Orlans, E. and Buttress, N. 1974.Eur. J. Immunol. 4:521)의 면역된 산란계에 형성된 항체가 난황에 효과적으로 전이된다는 보고에 의하여 난황 또는 면역글로블린의 활용성이 검정되었다.Immunoglobulins in egg yolks can be used not only as a source of immunoglobulins, but also as food ingredients (Shimizu, M., Fitzsimmons, RC and Nakai, S. 1988. J. Food. Sic . 53 (5). ): 1360-1366). In particular, yolks or immunoglobulins are reported by the report that antibodies formed in the immunized laying hens of Rose et al. (Rose, ME, Orlans, E. and Buttress, N. 1974. Eur. The utility of was tested.

또한 장독성 대장균으로부터 K88, K99, 987P를 순수분리, 정제하여 만든 서브유닛(subunit) 백신이 산란계에 면역원성 및 항체 지속성이 있음이 확인되었고,난황으로부터 분리한 특이 면역글로블린의 역가가 연구되었다(Svendsen, L., Crowly, A. and Ostergaard, L. H. 1995. Laboratory Animal Science. 45:89-93 ; Kim, J. W., Cho, S. H. and Koh, S. Y. 1998. The 8th world conference on animal production. Contributed papers-Vol. II. 36-37 ; Kim, J. W., Kim, C., Koh, S. Y. and Cho, S. H. 1998b. The 8th world conference on animal production. Contributed papers-Vol. II. 424-425 ; 김정우, 김도균, 김철. 2000. 장관독성 대장균 K99(F5)의 섬모항원에 대한 특이 난황항체의 생산. 한국동물자원과학회지. 42:371-378).In addition, it was confirmed that subunit vaccines prepared by purely separating and purifying K88, K99, and 987P from enterococci E. coli have immunogenicity and antibody persistence in laying hens, and titers of specific immunoglobulins isolated from egg yolk were studied. Svendsen, L., Crowly, A. and Ostergaard, LH 1995.Laboratory Animal Science.45: 89-93; Kim, JW, Cho, SH and Koh, SY 1998.The 8th world conference on animal production. Contributed papers-Vol II.36-37; Kim, JW, Kim, C., Koh, SY and Cho, SH 1998b.The 8th world conference on animal production. Contributed papers-Vol. II.424-425; Kim Jung-woo, Kim Do-gyun, Kim Chul. 2000. Production of specific yolk antibodies against ciliated antigens of enterotoxic Escherichia coli K99 (F5), Korean Journal of Animal Science and Technology, 42: 371-378).

하지만, 난황항체는 산란계에게 접종하는 항원에 따라 항체역가가 다양하게 나타나며 2가지 이상의 항원에 대한 난황항체의 연구는 미진한 상태일 뿐만 아니라 국내 양돈장에서 빈번히 발생하는 균주에 대한 난황항체의 연구는 전무한 편이다.However, egg yolk antibodies have various antibody titers depending on the antigens inoculated into laying hens, and there are few studies on egg yolk antibodies against two or more antigens, and there are no studies on yolk antibodies on strains that occur frequently in domestic pig farms. to be.

본 발명은 동물의 건강을 증진시킬 수 있는 사료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a feed composition capable of improving the health of an animal.

또한 본 발명은 항생제를 포함하는 사료를 대체할 수 있는 사료 조성물을 제공하는 것을 목적으로 한다.It is also an object of the present invention to provide a feed composition that can replace a feed comprising an antibiotic.

또한 본 발명은 동물의 질병 발생율을 감소시킬 수 있는 사료 조성물을 제공하는 것을 목적으로 한다.It is also an object of the present invention to provide a feed composition that can reduce the incidence of disease in animals.

상기 목적을 달성하기 위하여 본 발명은 F4:K88, F5:K99, F6:987P, F18 및F41로 이루어진 군으로부터 1종이상 선택된 항원으로 면역화된 산란계로부터 수득한 달걀을 0.1 내지 10 중량 %로 포함하는 사료 조성물을 제공한다.In order to achieve the above object, the present invention comprises from 0.1 to 10% by weight of an egg obtained from a laying hens immunized with at least one selected antigen from the group consisting of F4: K88, F5: K99, F6: 987P, F18 and F41 Provide a feed composition.

이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 항생제를 포함하지 않고도 가축의 건강을 증진시키고, 병원성 세균에 의한 질환을 예방할 수 있는 사료 조성물을 개발하였다.The present invention has developed a feed composition that can enhance the health of livestock and prevent diseases caused by pathogenic bacteria without including antibiotics.

본 발명의 사료 조성물은 통상의 가축사료 조성물에 난황항체를 포함하고 있다. 상기 난황항체는 가축에게 질병을 일으키는 세균에 의해 면역화된 산란계에서 수득되어진 것으로, 상기 세균에 대한 특이적 항체가 포함되어있다.Feed composition of the present invention comprises a yolk antibody in a conventional livestock feed composition. The egg yolk antibody is obtained from a laying hen immunized by a bacterium causing disease in livestock, and contains specific antibodies against the bacterium.

상기 통상의 가축사료 조성물은 가축에게 사용되는 모든 종류의 조성물이 바람직하고, 특히 항생제는 포함하는 사료에서 항생제를 제외한 것이다. 가장 바람직하게는 3,340 kcal ME/kg, 15 내지 25 중량%의 조단백질, 1 내지 2 중량%의 라이신을 함유하고 있는 것이다. 일예로, 옥수수 35 내지 45 중량%, 건조유청 20 내지 30 중량%, 대두박 10 내지 20 중량%, 대두단백 5 내지 15.00 중량%, 분무건조혈분 0.5 내지 8 중량%, 어분 0.5 내지 8 중량%, 동물성 지방 1 내지 5 중량%, 인산칼슘 0.5 내지 5 중량%, 석회석 0.05 내지 3 중량%, 비타민 광물질 프리믹스 0.05 내지 1 중량%, 소금 0.01 내지 3 중량%, 라이신 0.01 내지 3 중량%, 및 메치오닌 0.01 내지 3 중량%를 포함하는 조성물이다.The conventional livestock feed composition is preferably all kinds of compositions used for livestock, in particular antibiotics are excluded from the feed containing the antibiotic. Most preferably it contains 3,340 kcal ME / kg, 15-25 wt% crude protein, 1-2 wt% lysine. For example, 35 to 45% by weight of corn, 20 to 30% by weight of dry whey, 10 to 20% by weight of soybean meal, 5 to 15.00% of soy protein, 0.5 to 8% by weight of spray dried blood meal, 0.5 to 8% by weight of fishmeal, animal 1-5% fat, 0.5-5% calcium phosphate, 0.05-3% limestone, 0.05-1% vitamin mineral premix, 0.01-3% salt, 0.01-3% lysine, and 0.01-3 methionine Composition comprising weight percent.

상기 가축에게 질병을 일으키는 세균은 모든 종류의 병원성 세균 및 바이러스가 바람직하며, 더욱 바람직하게는 돼지, 소, 개, 고양이, 염소, 산양과 동물에서 발생되는 병인인 세균이다. 일예로 돼지질병은 설사병, 콜레라, 일본뇌염, 돼지전염성 위장염, 오제스키병, 돼지생식기호흡기증후군, 돼지위축성비염, 돼지마이코프라즈마성 폐렴, 돼지파스튜렐라폐렴, 돼지대장균증, 돼지단독, 톡소프라즈마병, 삼출성표피염, 돼지살모넬라증 등이 있다.Bacteria causing disease in livestock are preferably all kinds of pathogenic bacteria and viruses, more preferably bacteria which are etiologies occurring in pigs, cows, dogs, cats, goats, goats and animals. For example, swine diseases include diarrhea, cholera, Japanese encephalitis, swine infectious gastroenteritis, Ozeski's disease, swine genital respiratory syndrome, swine atrophic rhinitis, swine mycoplasma pneumonia, swine pasturela pneumonia, swine coliformosis, swine monologue, toxoplasma disease, Exudative epidermal infection, swine salmonellosis, and the like.

상기 병원성 세균에 대한 산란계 면역은 통상의 난황항체제조방법으로 실시하며, 산란계에 생균, 불활성화된 균, 파쇄된 균, 또는 균의 특이적 항원을 주입하여 산란계를 면역시킨다. 또한 산란계의 면역은 단일 항원에 대하여 실시할 수 있으며, 1종 이상의 항원을 혼합하여 산란계의 면역을 유도할 수 있다. 바람직한 항체는 F4:K88, F5:K99, F6:987P, F18 또는 F41에 대한 것으로, 상기 5종은 통상의 백신제조방법으로 불활성시키거나, 파쇄된 분획, 또는 혈청형을 나타내는 항원단백질을 항원으로 사용하는 것이 좋다.The laying hen immunity to the pathogenic bacteria is carried out by a conventional egg yolk antibody manufacturing method, and the laying hens are immunized by injecting a specific antigen of live bacteria, inactivated bacteria, crushed bacteria, or bacteria. In addition, the laying hens can be immunized against a single antigen, and one or more antigens can be mixed to induce the hens. Preferred antibodies are against F4: K88, F5: K99, F6: 987P, F18 or F41, the five of which are inactivated by conventional vaccine production methods, or an antigenic protein that shows a fragmented fraction or serotype as an antigen. It is good to use.

본 발명의 바람직한 특이적 항체를 포함하는 난의 제조방법은 공지된 기술(대한민국 특허 제0280331호, 대한민국 특허 제0280332호, 대한민국 특허 제0280333호)에 의해 실시되는 것이다.The method for producing an egg containing a preferred specific antibody of the present invention is carried out by known techniques (Korean Patent No. 0280331, Korean Patent No. 0280332, Korean Patent No. 0280333).

특이적 항체를 포함하는 난은 난내의 면역글로블린만을 추출하여 가축사료에 혼합하거나, 난을 가축사료에 혼합하여 난황항체를 포함하는 가축사료를 제조한다.Eggs containing specific antibodies are extracted only from immunoglobulins in eggs and mixed in animal feed, or eggs are mixed in animal feed to prepare livestock feed containing egg yolk antibodies.

난을 가축사료에 혼합할 경우, 난을 건조, 분말화하여 혼합하거나, 펠렛상으로 혼합할 수 있으며, 가장 바람직하기로는 분무건조하여 분말상으로 가축사료 0.1 내지 10 중량%로 혼합하는 것이 좋다. 혼합비는 난황항체의 역가에 따라 달리 조절하는 것이 바람직하지만, 통상적으로 가축사료 조성물에 난황항체를 함유한 난을 0.1 중량% 미만으로 첨가하며, 가축의 면역성 증진효과가 현저히 감소하며, 10 중량 % 초과할 경우, 사료의 생산 가격 상승과 경제성 감소, 사료의 기호성 감소 등 여러 가지 문제점이 발생될 수 있다.When the eggs are mixed with animal feed, the eggs may be dried, powdered and mixed, or mixed into pellets. Most preferably, the eggs are spray-dried and mixed with 0.1 to 10% by weight of livestock feed. Although the mixing ratio is preferably adjusted differently according to the titer of the yolk antibody, the animal feed composition generally contains less than 0.1% by weight of egg containing the yolk antibody, and the effect of enhancing the immunity of the animal is significantly reduced, and the weight exceeds 10% by weight. If so, various problems may occur such as an increase in the production price of the feed, a decrease in economic efficiency, and a decrease in the palatability of the feed.

본 발명의 난황항체를 포함하는 가축사료 조성물은 난황항체로 인하여 가축에게 병원성 세균에 대한 예방 및 치료효과를 유도할 수 있으며, 항생제의 사용없이 가축의 건강을 유지시킬 수 있다. 또한 항생제의 부작용을 예방할 수 있을 뿐만 아니라 간단하고 쉽게 가축의 면역성을 향상시킬 수 있다.Livestock feed composition comprising the yolk antibody of the present invention can induce a preventive and therapeutic effect on pathogenic bacteria to livestock due to the yolk antibody, it is possible to maintain the health of the livestock without the use of antibiotics. In addition, the side effects of antibiotics can be prevented as well as simple and easy to improve the immunity of livestock.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐 본 발명이 하기의 실시예에 한정되는 것은 아니다.Hereinafter, preferred examples are provided to aid in understanding the present invention. However, the following examples are provided only to more easily understand the present invention, and the present invention is not limited to the following examples.

[실시예 1]Example 1

항체를 포함하는 난 준비Egg preparations containing antibodies

국내 양돈장에서 어린 돼지에 있어 설사증을 유발시키는 장독성 대장균 K88과 987P로부터 섬모항원을 분리 및 동정하여 산란계에 면역한 후, 특이난황항체를 함유한 달걀을 수거하여 난각은 파기하고, 전란액만을 회수하여 분무건조기를 이용하여 건조하여 분말화함으로써 분무건조 달걀을 준비하였다. 구체적인 난황항체 준비실험은 공지된 기술(대한민국 특허 제0280331호, 대한민국 특허 제0280332호, 특허 제0280333호)에 따라 실시하였다.Isolates and identifies cilia antigens from enterococci E. coli K88 and 987P, which cause diarrhea in young pigs in domestic pig farms, to immunize laying hens. To dry by spray drying using a spray dryer to prepare a spray dried egg. Specific yolk antibody preparation experiment was carried out according to known techniques (Korean Patent No. 0280331, Korean Patent No. 0280332, Patent No. 0280333).

옥수수 40.70 중량%, 건조유청 25.00 중량%, 대두박 15.21 중량%, 대두단백 10.00 중량%, 분무건조혈분 2.00 중량%, 어분 2.50 중량%, 동물성 지방 2.50 중량%, 인산칼슘 1.30 중량%, 석회석 0.15 중량%, 비타민 광물질 프리믹스 0.22 중량%, 소금 0.20 중량%, 라이신 0.15 중량%, 및 메치오닌 0.07 중량%로 기초사료를 제조하고, 상기 기초사료에 분무건조 달걀 0.1 중량%를 혼합하여 가축사료를 제조하였다.Corn 40.70%, Dry Whey 25.00%, Soybean Meal 15.21%, Soy Protein 10.00%, Dry Dried Blood Powder 2.00%, Fish Meal 2.50%, Animal Fat 2.50%, Calcium Phosphate 1.30%, Limestone 0.15% To prepare a basic feed, 0.22 wt% of vitamin mineral premix, 0.20 wt% of salt, 0.15 wt% of lysine, and 0.07 wt% of methionine, and 0.1 wt% of spray dried eggs were mixed with the base feed to prepare livestock feed.

상기 기초사료는 미국사양표준지침(NRC. 1998. Nutrient requirements of swine(10th ed.). National Academy Press, Washington. D. C.)을 기초로 하여 3,340 kcal ME/kg, 22.00 중량%의 조단백질, 1.50 중량%의 라이신을 함유하고 있다.The basic feed is 3,340 kcal ME / kg, 22.00 wt.% Crude protein, 1.50 wt.% Based on the American National Standard Guideline (NRC. 1998. Nutrient requirements of swine (10th ed.) National Academy Press, Washington. DC). Contains lysine.

[실시예 2]Example 2

상기 실시예 1과 동일하게 실시하였고, 분무건조 달걀은 0.2 중량%를 사용하여 가축사료를 제조하였다.Was carried out in the same manner as in Example 1, using a spray dried egg 0.2% by weight to prepare a livestock feed.

[실시예 3]Example 3

상기 실시예 1과 동일하게 실시하였고, 분무건조 달걀은 0.3 중량%를 사용하여 가축사료를 제조하였다.Was carried out in the same manner as in Example 1, using a spray dried egg 0.3% by weight to prepare a livestock feed.

[실시예 4]Example 4

상기 실시예 1과 동일하게 실시하였고, 분무건조 달걀은 0.4 중량%를 사용하여 가축사료를 제조하였다.Was carried out in the same manner as in Example 1, the spray-dried eggs were prepared livestock feed using 0.4% by weight.

[비교예 1]Comparative Example 1

옥수수 40.70 중량%, 건조유청 25.00 중량%, 대두박 15.21 중량%, 대두단백 10.00 중량%, 분무건조혈분 2.00 중량%, 어분 2.50 중량%, 동물성 지방 2.50 중량%, 인산칼슘 1.30 중량%, 석회석 0.15 중량%, 비타민 광물질 프리믹스 0.22 중량%, 소금 0.20 중량%, 라이신 0.15 중량% 및 메치오닌 0.07 중량%를 혼합하여 가축사료를 제조하였다.Corn 40.70%, Dry Whey 25.00%, Soybean Meal 15.21%, Soy Protein 10.00%, Dry Dried Blood Powder 2.00%, Fish Meal 2.50%, Animal Fat 2.50%, Calcium Phosphate 1.30%, Limestone 0.15% Animal feed was prepared by mixing 0.22 wt% of vitamin mineral premix, 0.20 wt% of salt, 0.15 wt% of lysine and 0.07 wt% of methionine.

[비교예 2]Comparative Example 2

상기 비교예 1에 항생제 Apralan??20(Korea Vetchem. Co. Ltd., Korea, Aplamycine)을 0.5 중량%로 첨가하여 가축사료를 제조하였다.Antibiotics Apralan in Comparative Example 1 ?? Animal feed was prepared by adding 20 (Korea Vetchem. Co. Ltd., Korea, Aplamycine) to 0.5 wt%.

[실험예 1]Experimental Example 1

가축은 두룩저어지(Duroc)×요오크셔(Yorkshire)×랜드레이스(Landrace)의 삼원교잡종 이유자돈으로서 72두 공시하였으며, 실험개시 전 체중은 5.04 ±0.09 kg이었다.The livestock was exposed to 72 heads of three-way hybrid weaning pigs from Duroc × Yorkshire × Landace. The body weight was 5.04 ± 0.09 kg before the start of the experiment.

사양시험은 단국대학교 부설 실험동물사육실에서 실시되었으며, 실시예 1 내지 4 또는 비교예 1 내지 2의 가축사료를 가루 형태로 이유자돈에게 제공하였고, 자유 채식토록 하였으며, 물은 자동급수기를 이용하여 자유로이 먹을 수 있도록 하였다. 체중 및 사료 섭취량은 시험 종료시에 측정하여 일당 증체량, 일당 사료섭취량, 사료효율(사료 중량 대비 체중증가량의 비율)을 계산하였다.(참고, ME : 대사에너지)Specification test was carried out in the experimental animal breeding room attached to Dankook University, the livestock feed of Examples 1 to 4 or Comparative Examples 1 to 2 was provided to the weaning pigs in the form of powder, free vegetarian, water was freely eaten using an automatic water dispenser To make it possible. Body weight and feed intake were measured at the end of the study to calculate daily gain, daily feed intake, and feed efficiency (ratio of weight gain to feed weight). (Reference, ME: metabolic energy)

실험결과는 SAS(SAS. 1988. SAS/STAT. User,s Guide(Release 6.03). SAS Inst. Inc., Cary, NC., general linear model procedure)로 통계처리하였고, 평균간 유의성(Duncan's multiple range test, Duncan, D. B. 1955. "Multiple range and multiple F test." Biometerics. 11:142)을 검정하였다.The results SAS (SAS. 1988. SAS / STAT . User, s Guide (Release 6.03). SAS Inst. Inc., Cary, NC., General linear model procedure) as was statistically, the average inter-significant (Duncan's multiple range test, Duncan, DB 1955. "Multiple range and multiple F test." Biometerics. 11: 142).

10일간 가축사료를 급여한 이유자돈에 대한 결과는 표 1에 나타내었다.The results for weaning pigs fed livestock feed for 10 days are shown in Table 1.

항목Item 비교예1Comparative Example 1 비교예 2Comparative Example 2 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 일당증체량(g)Daily weight gain (g) 205205 287287 260260 288288 288288 293293 일당사료섭취량(g)Daily feed intake (g) 339339 419419 370370 385385 392392 387387 사료효율Feed efficiency 0.6050.605 0.6850.685 0.7030.703 0.7480.748 0.7350.735 0.7570.757

상기 표 1에 나타난 바와 같이, 이유자돈 72두를 10일간 시험하였을 때 난황항체의 첨가수준이 증가함에 따라 일당증체량(성장률)이 증가하는 경향이 나타났으나, 비교예 1을 제외한 비교예 2 및 실시예 1내지 4의 가축사료를 섭취한 이유자돈내에서는 통계적으로 유의적인 차이를 보이지 않았다.As shown in Table 1, when 72 heads of weaned pigs were tested for 10 days, the daily weight gain (growth rate) increased as the yolk antibody was added, but Comparative Example 2 and the practice except Comparative Example 1 were observed. There were no statistically significant differences in weaning pigs that consumed animal feeds of Examples 1-4.

일당사료섭취량에 있어서는 비교예 1의 처리구가 다른 처리구에 비교하여 사료섭취량이 높은 것으로 나타났으나, 처리구간에 유의적인 차이는 보이지 않았다.In the daily feed intake was shown that the feed intake of Comparative Example 1 was higher than the other treatment, but there was no significant difference in the treatment period.

사료효율에 있어서는 실시예 1 내지 실시예 4 처리구가 비교예 2 처리구에 비하여 유의적인 차이는 보이지 않았다. 하지만 실시예 1내지 실시예 4 및 비교예 2 처리구는 비교예 1 처리구에 비해 사료효율이 향상되었다(P<0.05). 또한 난황항체 첨가수준에 따라 사료효율이 증가하는 경향을 보였다.There was no significant difference in feed efficiency between the Examples 1 to 4 treatments compared to the Comparative Example 2 treatments. However, Example 1 to Example 4 and Comparative Example 2 treatment group was improved feed efficiency compared to Comparative Example 1 treatment group (P <0.05). Feed efficiency increased with egg yolk antibody level.

따라서, 기초사료에, 항생제 대신 특이난황항체를 함유한 달걀을 분무건조한 분말을 0.1∼0.4 중량% 혼합시키는 경우, 항생제를 투여하였을 때와 이유자돈의 성장률이 향상되는 것을 알 수 있다.Therefore, it can be seen that when the base feed is mixed with 0.1 to 0.4% by weight of the spray-dried powder of the egg containing the specific yolk antibody instead of the antibiotic, the growth rate of the weaning pig and the weaning pig are improved.

[실험예 2]Experimental Example 2

실험예 1의 사양시험 개시 3일 후에 모든 처리구에 장독성 대장균 K88(6.0×109cfu/ml)과 987P(1.2×1010cfu/ml)를 각각 1 ml씩 경구로 공격 접종하여 설사를 유발시켰다. 장독성 대장균 K88과 987P를 공격접종한 후 2일과 4일째 되는 날에 FC 수치(Sherman, D. M., Acres. S. D., Sadowski, P. L., Springer, J. A., Bray, B., Raybould, T. J. G. and Muscoplat, C. C. 1983.Infect. Immun. 42:656-658, 정상적인 분: 0, 연변: 1, 묽은 설사: 2, 심한 설사: 3)를 측정하였다. 그 결과는 하기 표 2에 나타내었다.Three days after the start of the specification test of Experimental Example, all treatments were challenged orally with 1 ml of enterococci E. coli K88 (6.0 × 10 9 cfu / ml) and 987P (1.2 × 10 10 cfu / ml), respectively, to induce diarrhea. I was. FC values (Sherman, DM, Acres.SD, Sadowski, PL, Springer, JA, Bray, B., Raybould, TJG and Muscoplat, CC 1983 on day 2 and 4 after challenge with E. coli K88 and 987P) Infect Immun 42: 656-658, normal minutes: 0, soft stool: 1, diarrhea diarrhea: 2, severe diarrhea: 3). The results are shown in Table 2 below.

항목Item 돼지 개체수Pig population 설사증을 일으키는 개체수Population causing diarrhea FC 수치FC figures 2일째Day 2 4일째Day 4 비교예 1Comparative Example 1 1212 6 (1.8)6 (1.8) 0 (0.4)0 (0.4) 비교예 2Comparative Example 2 1212 2 (1.0)2 (1.0) 1 (0.4)1 (0.4) 실시예 1Example 1 1212 2 (0.9)2 (0.9) 0 (0.4)0 (0.4) 실시예 2Example 2 1212 4 (1.2)4 (1.2) 1 (0.6)1 (0.6) 실시예 3Example 3 1212 2 (0.5)2 (0.5) 0 (0.2)0 (0.2) 실시예 4Example 4 1212 1 (0.5)1 (0.5) 0 (0.3)0 (0.3)

설사유발 2일째, 비교예 1 처리구의 설사 발생율은 50 %였으며, 실시예 2 처리구를 제외한 실시예 1, 실시예 3 내지 실시예 4, 비교예 3 처리구에서는 설사 발생율이 17 % 이하로 나타났다. 또한, 장독성 대장균 K88과 987P를 공격접종 후 4일째 되는 날의 FC 수치를 비교해보면, 모든 처리구에서 FC 수치가 0.6 이하로 대부분의 개체에서 설사가 멈춤을 알 수 있었다.On the second day of diarrhea, the incidence of diarrhea in the treatment group of Comparative Example 1 was 50%, and the incidence of diarrhea was 17% or less in the treatment groups of Examples 1, 3 to 4, and Comparative Example 3 except for the treatment group of Example 2. In addition, comparing the FC values on the day 4 after challenge with E. coli K88 and 987P, it was found that diarrhea stopped in most individuals with FC values of 0.6 or less in all treatments.

상기 결과에서, 실시예 4 처리구는 설사유도시 설사발생율이 현저히 낮아, 설사병을 예방할 수 있음을 알 수 있었고, 그외 실시예들의 처리구 역시 항생제 혼합 가축사료 처리구와 유사한 설사예방효과를 나타내었으며, 설사발생 후 항생제 혼합 가축사료 처리구에 비해 다소 향상된 치료효과를 나타내었다. 따라서, 특이난황항체를 함유한 달걀을 분무건조한 분말을 이유자돈 사료내에 0.1∼0.4 중량%첨가시 항생제를 대체할 수 있다.In the above results, the treatment of Example 4 was found to be significantly lower diarrhea induction diarrhea incidence, it was possible to prevent diarrheal disease, the treatment of the other examples also showed a diarrhea prevention effect similar to antibiotic mixed animal feed treatment, diarrhea development After treatment with antibiotics, it showed a slightly improved treatment effect. Therefore, it is possible to replace the antibiotic when 0.1-0.4% by weight of the egg-dried powder containing the egg yolk antibody is added to the weaning pig feed.

이상에서 살펴본 바와 같이, 본 발명의 난황항체를 포함하는 가축사료 조성물은 항생제 사용을 대체할 수 있으며, 쉽고 간편하게 가축의 면역성 및 건강을 증진시킨다.As described above, the livestock feed composition comprising the yolk antibody of the present invention can replace the use of antibiotics, and easily and simply improves the immunity and health of the livestock.

Claims (2)

F4:K88, F5:K99, F6:987P, F18 및 F41로 이루어진 군으로부터 1종이상 선택된 항원으로 면역화된 산란계로부터 수득한 달걀을 0.1 내지 10 중량 %로 포함하는 사료 조성물.A feed composition comprising from 0.1 to 10% by weight of an egg obtained from a laying hen immunized with at least one antigen selected from the group consisting of F4: K88, F5: K99, F6: 987P, F18 and F41. 제 1 항에 있어서, 상기 사료조성물은 옥수수 35 내지 45 중량%, 건조유청 20 내지 30 중량%, 대두박 10 내지 20 중량%, 대두단백 5 내지 15.00 중량%, 분무건조혈분 0.5 내지 8 중량%, 어분 0.5 내지 8 중량%, 동물성 지방 1 내지 5 중량%, 인산칼슘 0.5 내지 5 중량%, 석회석 0.05 내지 3 중량%, 비타민 광물질 프리믹스 0.05 내지 1 중량%, 소금 0.01 내지 3 중량%, 라이신 0.01 내지 3 중량%, 및 메치오닌 0.01 내지 3 중량%로 더욱 포함하는 사료 조성물.According to claim 1, wherein the feed composition is 35 to 45% by weight corn, 20 to 30% by weight dry whey, 10 to 20% by weight soybean meal, 5 to 15.00% by weight soy protein, 0.5 to 8% by weight of spray dried blood meal, fish meal 0.5-8 wt%, animal fat 1-5 wt%, calcium phosphate 0.5-5 wt%, limestone 0.05-3 wt%, vitamin mineral premix 0.05-1 wt%, salt 0.01-3 wt%, lysine 0.01-3 wt% Feed composition further comprises 0.01% to 3% by weight, and methionine.
KR1020010046638A 2001-08-01 2001-08-01 Feed compound for substituting antibiotic KR20030012563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010046638A KR20030012563A (en) 2001-08-01 2001-08-01 Feed compound for substituting antibiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010046638A KR20030012563A (en) 2001-08-01 2001-08-01 Feed compound for substituting antibiotic

Publications (1)

Publication Number Publication Date
KR20030012563A true KR20030012563A (en) 2003-02-12

Family

ID=27717717

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010046638A KR20030012563A (en) 2001-08-01 2001-08-01 Feed compound for substituting antibiotic

Country Status (1)

Country Link
KR (1) KR20030012563A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104304672A (en) * 2014-09-19 2015-01-28 山东贝瑞康生物科技有限公司 Feed containing immune active substances, preparation method and special preparation device thereof
CN113331320A (en) * 2021-06-15 2021-09-03 贵州船牌饲料有限公司 Preparation method and production equipment of special feed for breeding channel catfish

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840008573A (en) * 1983-04-25 1984-12-17 김봉호 Combined Animal Feed
KR880003632A (en) * 1985-11-25 1988-05-28 히데오 도고로 Specific antibody-containing material from egg, manufacturing method and use thereof
KR950016549A (en) * 1993-12-29 1995-07-20 유영학 Method for preparing animal feed composition containing fermented cells
KR970068862A (en) * 1996-04-27 1997-11-07 김광희 Anionic feed composition for dry organic cows
JPH10265393A (en) * 1997-03-25 1998-10-06 Natl Fedelation Of Agricult Coop Assoc Medicine for preventing and treating porcine epidemic diarrhea
KR100267747B1 (en) * 1998-04-03 2000-10-16 이재진 Complex immunological preparation containing egg-yolk antibodies, for prevention and treatment of porcine diarrhea caused by enterotoxigenic escherichia coli or porcine epidemic diarrhea virus
KR20010037612A (en) * 1999-10-19 2001-05-15 이재진 Feed additive containing the dried powder of egg-yolk antibodies, for prevention and treatment of Porcine diarrhea caused by enterotoxigenic Escherichia coli
WO2001048018A1 (en) * 1999-12-27 2001-07-05 University Of Manitoba Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840008573A (en) * 1983-04-25 1984-12-17 김봉호 Combined Animal Feed
KR880003632A (en) * 1985-11-25 1988-05-28 히데오 도고로 Specific antibody-containing material from egg, manufacturing method and use thereof
KR950016549A (en) * 1993-12-29 1995-07-20 유영학 Method for preparing animal feed composition containing fermented cells
KR970068862A (en) * 1996-04-27 1997-11-07 김광희 Anionic feed composition for dry organic cows
JPH10265393A (en) * 1997-03-25 1998-10-06 Natl Fedelation Of Agricult Coop Assoc Medicine for preventing and treating porcine epidemic diarrhea
KR100267747B1 (en) * 1998-04-03 2000-10-16 이재진 Complex immunological preparation containing egg-yolk antibodies, for prevention and treatment of porcine diarrhea caused by enterotoxigenic escherichia coli or porcine epidemic diarrhea virus
KR20010037612A (en) * 1999-10-19 2001-05-15 이재진 Feed additive containing the dried powder of egg-yolk antibodies, for prevention and treatment of Porcine diarrhea caused by enterotoxigenic Escherichia coli
WO2001048018A1 (en) * 1999-12-27 2001-07-05 University Of Manitoba Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104304672A (en) * 2014-09-19 2015-01-28 山东贝瑞康生物科技有限公司 Feed containing immune active substances, preparation method and special preparation device thereof
CN113331320A (en) * 2021-06-15 2021-09-03 贵州船牌饲料有限公司 Preparation method and production equipment of special feed for breeding channel catfish

Similar Documents

Publication Publication Date Title
Gharib et al. Comparison of the effects of probiotic, organic acid and medicinal plant on Campylobacter jejuni challenged broiler chickens
RU2673233C2 (en) Clay product and uses thereof
Mahdavi et al. Effects of dietary egg yolk antibody powder on growth performance, intestinal Escherichia coli colonization, and immunocompetence of challenged broiler chicks
JP5645843B2 (en) Compositions and methods for controlling disease in animals
AU2005211140B2 (en) Use of live bacteria for growth promotion in animals
Korver Overview of the immune dynamics of the digestive system
Quigley Iii et al. Effects of oral antibiotics or bovine plasma on survival, health and growth in dairy calves challenged with Escherichia coli
US20050163802A1 (en) Method
Bosi et al. Effect of different spray dried plasmas on growth, ileal digestibility, nutrient deposition, immunity and health of early-weaned pigs challenged with E. coli K88
Karamzadeh-Dehaghani et al. Combined effect of probiotics and specific immunoglobulin Y directed against Escherichia coli on growth performance, diarrhea incidence, and immune system in calves
EP0955061A1 (en) Oral product for the prevention and therapy of porcine gastroenteric infections
Murayama et al. Effects of orally administered Clostridium butyricum MIYAIRI 588 on mucosal immunity in mice
Ren et al. Isoleucine attenuates infection induced by E. coli challenge through the modulation of intestinal endogenous antimicrobial peptide expression and the inhibition of the increase in plasma endotoxin and IL-6 in weaned pigs
EP0914778A1 (en) Oral administration of bacteria at a concentration which produces cell-mediated immunity and weight in certain animals
EP0914831B1 (en) Biological product for preventive or therapeutic oral administration against canine parvovirosis
KR20030012563A (en) Feed compound for substituting antibiotic
US7045149B2 (en) Ruminal fluid inoculation of calves
Jabbari et al. Effects of Protexin Probiotic and Aquablend Avian Antibody on Performance and Immune System of Broiler Chickens
Hedayati et al. Combination effect of probiotic and organic acids on blood biochemistry and immunity parameters of broilers
US20240122953A1 (en) Methods for reducing pathogenic e coli by selective feed additive intervention
KR19990079334A (en) Oral immunization with yolk antibody for prevention and treatment of swine coli diarrhea
Karamzadeh-Dehaghani et al. The international journal of animal biosciences
Botlhoko Performance of Clostridium perfringens-challenged broilers inoculated with Effective Microorganisms
WO2022175267A1 (en) Methods for reducing pathogenic e coli by selective feed additive intervention
Valpotić et al. Evaluation of the prophylactic potential of non-enterotoxigenic Escherichia coli (non-ETEC) vaccine immunization and dietary mannan oligosaccharide competitive exclusion benefits against ETEC infections in weaned pigs

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application